Cargando…

Editorial: Novel biomarkers for clinical and molecular stratification of organ involvement in rheumatic diseases

Detalles Bibliográficos
Autores principales:	Sun, Xiaolin, Pan, Miao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494712/ https://www.ncbi.nlm.nih.gov/pubmed/37700772 http://dx.doi.org/10.3389/fmed.2023.1274950

Ejemplares similares

Editorial: Molecular markers in rheumatic diseases and their comorbidities
por: Vazquez-Del Mercado, Monica, et al.
Publicado: (2023)

Editorial: Innovation in Rheumatic Diseases
por: Jacinto, Maria João, et al.
Publicado: (2022)

Editorial: Rheumatic Diseases and Infection
por: Dong, Lingli, et al.
Publicado: (2022)

Editorial: Comorbidity Burden in Rheumatic Diseases
por: Nikiphorou, Elena, et al.
Publicado: (2018)

Editorial: Nutrition and Metabolism in Rheumatic Diseases
por: Canhao, Helena, et al.
Publicado: (2019)

Editorial: Infection-Related Rheumatic Diseases
por: Thomas, Konstantinos, et al.
Publicado: (2021)

Editorial: Osteoporosis in Rheumatic Diseases, What's New?
por: Ruaro, Barbara, et al.
Publicado: (2021)

Editorial: Drug Survival: Treatment of Rheumatic Diseases in the Biologic Era
por: Di Sanzo, Lorenzo, et al.
Publicado: (2022)

Editorial: Psychological impact and quality of life in rheumatic and musculoskeletal diseases
por: Talarico, Rosaria, et al.
Publicado: (2023)

Editorial: Multidisciplinary approach to interstitial lung disease associated with systemic rheumatic diseases
por: Sambataro, Gianluca, et al.
Publicado: (2022)

Editorial: Advance in B-cell therapies for the treatment of rheumatic and musculoskeletal diseases
por: Md Yusof, Md Yuzaiful, et al.
Publicado: (2022)

Editorial: Omics for the objective diagnosis and management of immune-mediated rheumatic diseases
por: Fu, Tieh-Cheng, et al.
Publicado: (2023)

Editorial: Novel phenotyping and risk stratification strategies for heart failure
por: Chan, Jeffrey Shi Kai, et al.
Publicado: (2023)

Editorial: Chronic rheumatic inflammatory conditions and cardiovascular health
por: Lo Gullo, Alberto, et al.
Publicado: (2022)

Editorial: Rheumatic fever: 21st century clinical and experimental insights
por: Nascimento, Bruno R., et al.
Publicado: (2023)

Editorial: Organ Fibrosis: Pathogenesis, Biomarkers and Therapeutic Targets
por: Mutsaers, Henricus A. M., et al.
Publicado: (2021)

Editorial: Classical and Novel Biomarkers for Cardiovascular Disease
por: Perticone, Maria, et al.
Publicado: (2022)

Integrating Tumor Stroma Biomarkers With Clinical Indicators for Colon Cancer Survival Stratification
por: Chen, Yong, et al.
Publicado: (2020)

Innovative Molecular Imaging for Clinical Research, Therapeutic Stratification, and Nosography in Neuroscience
por: Beaurain, Marie, et al.
Publicado: (2019)

Editorial: Biomarkers in Pulmonary Diseases
por: Mahboub, Bassam, et al.
Publicado: (2022)

Diagnosing lung involvement in inflammatory rheumatic diseases—Where do we currently stand?
por: Hoffmann, Tobias, et al.
Publicado: (2023)

Editorial: Molecular Pathophysiology of Diabetes-Related Organ Injury
por: Zhao, Tingting, et al.
Publicado: (2022)

Editorial: Risk Stratification Strategies for Cardiac Rhythm Abnormalities
por: Tse, Gary, et al.
Publicado: (2022)

Immunomics in Pediatric Rheumatic Diseases
por: Tay, Shi Huan, et al.
Publicado: (2019)

IL-33 in Rheumatic Diseases
por: Dong, Yuanji, et al.
Publicado: (2021)

Toward Molecular Stratification and Precision Medicine in Systemic Sclerosis
por: Noviani, Maria, et al.
Publicado: (2022)

Interstitial Lung Disease Associated With Autoimmune Rheumatic Diseases: Checklists for Clinical Practice
por: Bosello, Silvia Laura, et al.
Publicado: (2021)

Editorial: Advances in systemic lupus erythematosus: The promises and pitfalls of personalized medicine and patient stratification
por: Marasco, Emiliano, et al.
Publicado: (2022)

Editorial: Recent Advances in Potential Biomarkers for Rheumatic Diseases and in Cell-Based Therapies in the Management of Inflammatory Rheumatic Diseases
por: Saas, Philippe, et al.
Publicado: (2022)

Editorial: Omics biomarkers in inflammatory ocular diseases
por: Ttakeuchi, Masaru, et al.
Publicado: (2022)

Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD
por: Marques, Vanda, et al.
Publicado: (2021)

Editorial: Molecular imaging in retinal diseases
por: Ahn, Seong Joon
Publicado: (2023)

Editorial: Biomarkers in CKD
por: Araujo, Magali, et al.
Publicado: (2017)

Rheumatic Fever and Rheumatic Heart Disease a Historical Perspective
por: Hajar, Rachel
Publicado: (2016)

Editorial: The role of novel hepatitis B biomarkers in solving therapeutic dilemmas
por: Lazarevic, Ivana, et al.
Publicado: (2023)

Editorial: Cardiovascular involvement in autoimmune diseases
por: Mavrogeni, Sophie I., et al.
Publicado: (2022)

Cardiovascular Imaging Techniques in Systemic Rheumatic Diseases
por: Atzeni, Fabiola, et al.
Publicado: (2018)

Rheumatic Manifestations and Diseases From Immune Checkpoint Inhibitors in Cancer Immunotherapy
por: Shen, Pan, et al.
Publicado: (2021)

Editorial: Frontiers in Autoimmune Disease: Rheumatic Fever and Rheumatic Heart Disease
por: Guilherme, Luiza, et al.
Publicado: (2015)

Classical Disease-Specific Autoantibodies in Systemic Sclerosis: Clinical Features, Gene Susceptibility, and Disease Stratification
por: Yang, Changyi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9hp5b041mr9vf0pat9punnmvep